STAT+: Despite court ruling, FDA will continue with its approach to approving orphan drug exclusivity
In an unexpected move, the U.S. Food and Drug Administration will continue to apply exclusive…
Category: Pharmaceuticals
STAT+: FTC wants ‘pharma bro’ Martin Shkreli held in contempt for violating lifelong ban on working in pharma
The U.S. Federal Trade Commission asked a federal judge to hold “pharma bro” Martin Shkreli…
Opinion: Biopharma leaders helped save democracy. Now what?
The rule of law must be upheld for free societies and free markets to flourish,…
Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs
With a few clicks, Daniel added the chemical to his online cart and ordered it….
STAT+: Major purchasers predict expensive new therapies will keep driving drug price hikes
More than two dozen big buyers of prescription medicines expect that prices will rise by…
STAT+: Large health insurers lowered barriers to fair access to some drugs, analysis finds
Most of the largest health plans in the U.S. generally provide “fair access” to 19…
.jpg)
Opinion: Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it
Two congressional committees recently released damning results of an 18-month investigation into the Food and…
Telehealth patients are scrambling for in-person care amid crackdown on online controlled substances
Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had…
STAT+: Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing…
STAT+: With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s…
STAT+: California is the latest state to sue drugmakers and PBMs over insulin pricing
The California attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers…
STAT+: Regeneron executive George Yancopoulos admits some regret, but ‘I don’t apologize’
SAN FRANCISCO — George Yancopoulos isn’t apologizing. The president and chief scientist of Regeneron was…
Opinion: Democratizing drug development will be a win for all
In 1992, the film Lorenzo’s Oil celebrated the true story of two parents who, despite…
.jpg)
STAT+: Medicare paves the way for CAR-T in doctors offices
WASHINGTON — Medicare officials have taken a step toward making a cutting-edge cancer treatment called…
STAT+: HHS will decide how to resolve $1 billion in payments for 340B hospitals
WASHINGTON — The Department of Health and Human Services will get to decide how to…
STAT+: FDA scolds Sun Pharmaceutical for serious quality control problems at a key plant in India
Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food…
STAT+: People hate drug ads on TV. Here’s what they complain about most
In the United States, pharmaceutical advertising seems inescapable. Since the first prescription drug ad ran…
STAT+: Regeneron’s Eylea sales dip, as competition looms
SAN FRANCISCO — Regeneron said Monday that it collected $1.5 billion in revenues from its…
India’s lax oversight of pharmaceutical manufacturing imperils health around the world
Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in…
Drugstores make slow headway on staffing problems
Joan Cohrs missed her chance to grab a prescription at her usual drugstore by about…
Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more
The pharmaceutical industry has been slow to adopt a business practice that is faster, safer,…
STAT+: Pharma’s ambitious antibiotic venture fund makes another investment
For only the second time since launching nearly two years ago, the AMR Action Fund…
STAT+: ‘Stuck in a rut’: As debate flares over access to medicines, the future of voluntary licensing is up in the air
ANNECY, FRANCE — At first blush, the deal was hailed as a breakthrough. Last fall,…
Walgreens to pursue certification to provide abortion pills in pharmacies
Walgreens plans to seek certification to begin providing abortion pills under new Food and Drug…
A letter from the executive editor: The Aduhelm Files
Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the…
Opinion: To effectively combat diabetes, policymakers must treat obesity like other diseases
Obesity is often included in the litany of chronic diseases that plague six in 10…
STAT+: California wants to revoke a CVS mail-order license for illegally filling opioid and ADHD prescriptions
California authorities are seeking to revoke a license held by a CVS Health mail-order pharmacy…
Pharma wins changes in bill regarding FDA’s accelerated approval
A bill that makes it easier for the Food and Drug Administration to withdraw drugs…
STAT+: Here are the finalists for best biopharma CEO of 2022. And a winner
It’s that time of the year again when we at STAT recognize the Best Biopharma…
STAT+: Eli Lilly diabetes drug Mounjaro in short supply, FDA says
The U.S. Food and Drug Administration has declared a shortage of Eli Lilly’s Mounjaro, the…
STAT+: Drugmakers ask regulators to change standards on new Covid antibody drugs for most vulnerable
Biotech executives and a handful of academics pleaded with U.S. and European regulators on Thursday…
STAT+: AbbVie exits major pharmaceutical industry lobbying groups
WASHINGTON — The maker of one of the world’s most profitable medicines is exiting the…
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States….
Getting hepatitis C treatment opens new doors for the incarcerated
WARREN, Maine — For the prisoners who receive it, hepatitis C treatment is more than…
For families, grieving an incarcerated person’s death adds complexity to an already painful process
PLEASANTON, Texas — The only thing worse than caring for a sick loved one in…
Watch: With little more than a typewriter, an Idaho man overturns the entire state’s policy on hepatitis C treatment in prison
BOISE, Idaho — When he took on the state department of corrections, Phil Turney didn’t…
Despite federal disclosure rules, state prisons hide information on hepatitis C-related deaths
It’s virtually impossible to get information from states and correctional facilities about why people die…
Prisons say they can’t afford to cure everyone with hepatitis C. But some are figuring out a way
State prison systems say they can’t afford to cure everyone with hepatitis C. The drug,…
Legal and medical experts say denying hepatitis C care is cruel and unusual punishment, but the courts are still catching up
The final years of Carl Hoffer’s life were, in his words, “living hell.” His legs…
These 8 states are doing the worst job of treating hepatitis C in prisons
In 2022, whether an incarcerated person gets cured of hepatitis C is largely determined by…
Opinion: To protect the medical supply chain, ‘made in America’ will be key
The Covid-19 pandemic exposed a serious flaw in the United States’ medical supply chain: an…
STAT+: New Biden changes to Obamacare coverage for generics splits the industry
WASHINGTON — The Biden administration signaled Monday that it will require health plans on federal…
STAT+: In bid to beat Bristol Myers, Takeda buys Nimbus’ anti-inflammatory drug drug for $4 billion
Takeda Pharmaceuticals said Tuesday it will spend $4 billion and offer another $2 billion in…
STAT+: Moderna cancer vaccine reduces melanoma’s return by 44%
An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant…
STAT+: Roche pharmaceuticals CEO Bill Anderson to step down after four-year-tenure
Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after…
STAT+: Mark Cuban teams with a business coalition in bid to lower drug costs for employers
In his latest bid to expand access to lower-cost medicines, Mark Cuban’s Cost Plus Drug…
STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines
Two years after an independent laboratory began pushing the U.S. Food and Drug Administration to…
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Touted by celebrities, raved about by TikTok users and advertised by med spas, a new…
STAT+: Zantac lawsuits are tossed out as judge lambasts lack of evidence showing links to cancer
Several big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $805 million in 2021
During 2021, drugmakers substantially raised prices on seven widely used medicines without any new clinical…